Fostering a thriving health innovation ecosystem
IFPMA champions innovation as the driving force behind progress in healthcare, contributing to healthier lives and societies.
This involves promoting awareness of the enabling conditions needed to support the innovation ecosystem, including access to a skilled workforce, efficient and resilient health systems, regulatory frameworks, and sound intellectual property protection.
We engage with global organizations and with the wider global health community on behalf of the industry to share its perspective, advocate in different fora, and support the development of policies that enable the industry to continue to innovate for health.
IFPMA fosters an understanding of the enabling role intellectual property (IP) plays in driving innovation in the pharmaceutical industry, ultimately making health breakthroughs happen.
Technology transfer plays a role in bridging R&D gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. IFPMA shares the value of technology transfer with policy leaders globally.
Representing an industry whose members have R&D and manufacturing operations around the world, IFPMA engages on behalf of the innovative pharmaceutical industry with global trade organizations.